Seoul, South Korea

Jang Jiyeon



 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jang Jiyeon

Introduction

Jang Jiyeon, an accomplished inventor based in Seoul, South Korea, has made significant strides in the realm of medical advancements. With a focus on tackling bacterial infections, particularly Tuberculosis, Jang's innovative contributions showcase his dedication to improving global health.

Latest Patents

Jang Jiyeon holds one patent for his groundbreaking work on anti-infective compounds. This invention involves small molecule compounds that are specifically designed for the treatment of bacterial infections, especially targeting Tuberculosis. His research is pivotal in developing more effective treatment options for one of the world's deadliest diseases.

Career Highlights

Throughout his illustrious career, Jang has worked with prominent research institutions, including Institut Pasteur Korea and the Institut National de la Santé et de la Recherche Médicale. His experience in these esteemed organizations has allowed him to hone his skills in research and innovation, ultimately leading to his notable patent.

Collaborations

In his journey as an inventor, Jang Jiyeon has collaborated with esteemed colleagues in his field, including Zaesung No and Jaeseung Kim. These collaborations have enhanced his research efforts, driving forward the development of valuable medical treatments.

Conclusion

Jang Jiyeon's innovative work in developing anti-infective compounds spotlights his commitment to addressing critical health challenges. As he continues to contribute to medical science through his patents and collaborations, the impact of his inventions will surely resonate within the healthcare community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…